Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer
· cardiff oncology, inc.
AI Briefing
- Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer
- Webinar to Discuss Emergent Treatment Landscape in First-Line RAS-mutated mCRC
- Event to Take Place on March 25th, 2026 at 4:30 p.m. ET
Advertisement